Research Topic · Peer-Reviewed

Recombinant Vaccines

Recombinant vaccines are vaccines produced using recombinant DNA technology, in which genes encoding specific antigens from a pathogen are inserted into host cells or organisms that then manufacture those antigens. Rather than using whole live or inactivated pathogens, these vaccines present purified proteins or ant…

Curated from this journal's research 📚 6 peer-reviewed articles cited Cited 5× across the literature 🔖 ISSN 2691-8862 🗓 Reviewed July 2026

Overview

Recombinant vaccines are vaccines produced using recombinant DNA technology, in which genes encoding specific antigens from a pathogen are inserted into host cells or organisms that then manufacture those antigens. Rather than using whole live or inactivated pathogens, these vaccines present purified proteins or antigenic components to the immune system, an approach that can improve safety and allow precise targeting of the immune response. Recombinant techniques underpin vaccines against a range of diseases and have become central to modern vaccine development, including subunit and protein-based formulations. Research in the journal touches on vaccine development relevant to this approach; for example, one study characterizes the Abdala vaccine, a recombinant protein-based COVID-19 vaccine, while other work explores antigen-delivery and adjuvant strategies, such as a nanoadjuvant developed for vaccination against tuberculosis, and broader discussions of COVID-19 vaccine development, prospects, and challenges. These investigations reflect ongoing efforts to design and evaluate vaccines that elicit effective and durable immune protection. This page brings together peer-reviewed, open-access research relevant to recombinant vaccines and the wider field of vaccine design, antigen delivery, and immunization against viral and other infectious diseases.

Research published in this journal

6 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

The Novel Coronavirus 2019 (COVID-19): A Narrative Review

Rezapour BarataliCorresponding author
Department of Public Health, Faculty of Health, Assistant Professor, PhD in Health education and promotion, Urmia University of Medical Sciences, Urmia, Iran
International Journal of Coronaviruses Cited by 2 doi:10.14302/issn.2692-1537.ijcv-20-3373
2021

Characterization of the Vaccine Abdala

Pino Marrero KatiaCorresponding author
Holguin's university of medical sciences, Cuba.
Current Viruses and Treatment Methodologies doi:10.14302/issn.2691-8862.jvat-21-3999

How this research is being cited

The 6 articles above have been cited 5 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Recombinant Vaccines, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Current Viruses and Treatment Methodologies (ISSN 2691-8862).

Journal editorial board
Dr. Anantha Harijith · United States

This page summarises published research for orientation; it is not medical or professional advice.